These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19352681)

  • 1. Renal cell carcinoma associated immunosuppressive therapy: a case report with Wegener's granulomatosis.
    Deger SM; Mutluay R; Ebinc FA; Arinsoy T; Sindel S
    Rheumatol Int; 2009 Nov; 30(1):119-21. PubMed ID: 19352681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis.
    Odeh M
    Scand J Rheumatol; 1996; 25(6):391-3. PubMed ID: 8996475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cancer and Wegener's granulomatosis: a case report.
    Bumbasirevic U; Dragicevic D; Janicic A; Cemerikic-Martinovic V; Cekerevac M; Aleksic V; Tulic C
    World J Surg Oncol; 2011 Dec; 9():165. PubMed ID: 22166090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma of the nasal septum with Wegener's granulomatosis treated with cyclophosphamide and corticosteroids.
    Wakisaka N; Tanaka S; Nagayama I; Furukawa M
    Auris Nasus Larynx; 1998 Dec; 25(4):393-6. PubMed ID: 9853662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.
    Springer J; Nutter B; Langford CA; Hoffman GS; Villa-Forte A
    Medicine (Baltimore); 2014 Mar; 93(2):82-90. PubMed ID: 24646464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy following intravenous cyclophosphamide therapy in a patient with Wegener's granulomatosis.
    Manthorpe R; Svensson O
    Clin Exp Rheumatol; 1996; 14(6):702-3. PubMed ID: 8978974
    [No Abstract]   [Full Text] [Related]  

  • 9. Wegener's granulomatosis masquerading as a renal cancer: a case report and review of the literature.
    Vandergheynst F; Van Gansbeke D; Cogan E
    Clin Exp Rheumatol; 2006; 24(5):584-6. PubMed ID: 17181931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum tolerable dose of cyclophosphamide and azathioprine in Pakistani patients with primary renal disease.
    Ali SS; Rabbani MA; Moinuddin SS; Virani S; Farooque F; Salam A; Ahmad A
    J Pak Med Assoc; 2004 Jan; 54(1):39-42. PubMed ID: 15058645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wegener's granulomatosis. Combined therapy with low-dosage systemic corticosteroids, azathioprine and cyclophosphamide in three patients.
    Keczkes K
    Br J Dermatol; 1976 Apr; 94(4):391-9. PubMed ID: 1268053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus retinitis in rheumatic disease: a case report.
    Winkler A; Finan MJ; Pressly T; Roberts R
    Arthritis Rheum; 1987 Jan; 30(1):106-8. PubMed ID: 3028432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis].
    Kovacević Z; Mitrović D; Tomić I; Jovanović D; Skatarić V; Dimitrijević J; Rabrenović V; Trifunović G
    Vojnosanit Pregl; 1999; 56(1):31-7. PubMed ID: 10230331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wegener's granulomatosis (morbus Wegener)].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2003 Nov; 92(46):1943-7. PubMed ID: 14765551
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener's granulomatosis.
    Mitrovic D; Popovic M; Stefanovic D; Glisic B; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2378-9. PubMed ID: 11377566
    [No Abstract]   [Full Text] [Related]  

  • 17. Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide?
    Ueno T; Sata M
    Intern Med; 2003 May; 42(5):379-80. PubMed ID: 12793704
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide.
    Steinman TI; Jaffe BF; Monaco AP; Wolff SM; Fauci AS
    Am J Med; 1980 Mar; 68(3):458-60. PubMed ID: 6987874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
    Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.